Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:597-606
Published online before print January 17, 2008, doi: 10.1161/CIRCRESAHA.107.165464
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/5/597    most recent
CIRCRESAHA.107.165464v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gonzalez, A.
Right arrow Articles by Leri, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, A.
Right arrow Articles by Leri, A.
Related Collections
Right arrow Congestive
Right arrow Cell biology/structural biology
Right arrow Gene expression
Right arrow Growth factors/cytokines
Right arrow Myogenesis
(Circulation Research. 2008;102:597.)
© 2008 American Heart Association, Inc.


Integrative Physiology

Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan

Arantxa Gonzalez*, Marcello Rota*, Daria Nurzynska*, Yu Misao, Jochen Tillmanns, Caroline Ojaimi, M. Elena Padin-Iruegas, Patrick Müller, Grazia Esposito, Claudia Bearzi, Serena Vitale, Buddhadeb Dawn, Santosh K. Sanganalmath, Mathue Baker, Thomas H. Hintze, Roberto Bolli, Konrad Urbanek, Toru Hosoda, Piero Anversa, Jan Kajstura, Annarosa Leri

From the Departments of Anesthesia and Medicine and Division of Cardiology (A.G., M.R., D.N., Y.M., J.T., M.E.P.-I., P.M., G.E., C.B., S.V., M.B., K.U., T.H., P.A., J.K., A.L.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Physiology (C.O., T.H.H.), New York Medical College, Valhalla, New York 10595; and Institute of Molecular Cardiology (B.D., S.K.S., R.B.), University of Louisville, Ky.

Correspondence to Annarosa Leri, MD, Departments of Anesthesia and Medicine and Division of Cardiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. E-mail aleri{at}zeus.bwh.harvard.edu

Heart failure is the leading cause of death in the elderly, but whether this is the result of a primary aging myopathy dictated by depletion of the cardiac progenitor cell (CPC) pool is unknown. Similarly, whether current lifespan reflects the ineluctable genetic clock or heart failure interferes with the genetically determined fate of the organ and organism is an important question. We have identified that chronological age leads to telomeric shortening in CPCs, which by necessity generate a differentiated progeny that rapidly acquires the senescent phenotype conditioning organ aging. CPC aging is mediated by attenuation of the insulin-like growth factor-1/insulin-like growth factor-1 receptor and hepatocyte growth factor/c-Met systems, which do not counteract any longer the CPC renin–angiotensin system, resulting in cellular senescence, growth arrest, and apoptosis. However, pulse-chase 5-bromodeoxyuridine–labeling assay revealed that the senescent heart contains functionally competent CPCs that have the properties of stem cells. This subset of telomerase-competent CPCs have long telomeres and, following activation, migrate to the regions of damage, where they generate a population of young cardiomyocytes, reversing partly the aging myopathy. The senescent heart phenotype and heart failure are corrected to some extent, leading to prolongation of maximum lifespan.


Key Words: aging cardiomyopathy • cardiac stem cells • telomere–telomerase system